EFFECTS OF NOREPINEPHRINE UPON LIPID METABOLISM IN A PATIENT WITH BILIARY CIRRHOSIS.
D001769:Blood; D001786:Blood Glucose; D002784:Cholesterol / Q000097:blood*; D005227:Fatty Acids / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D005989:Glycerides; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins; D008099:Liver / Q000502:physiology*; D008105:Liver Cirrhosis, Biliary; D009638:Norepinephrine; D010600:Pharmacology; D010743:Phospholipids
D001786:Blood Glucose; D005227:Fatty Acids; D005989:Glycerides; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D002784:Cholesterol; D005947:Glucose; D009638:Norepinephrine
BLOOD; BLOOD CHOLESTEROL; BLOOD LIPIDS; BLOOD SUGAR; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLYCERIDES; LIPID METABOLISM; LIPOPROTEINS; LIVER CIRRHOSIS, OBSTRUCTIVE; LIVER FUNCTION; NOREPINEPHRINE; PHARMACOLOGY; PHOSPHOLIPIDS